Author:
Pink Richard,Hudson Alan,Mouriès Marie-Annick,Bendig Mary
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference110 articles.
1. Trouiller, P. et al. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 359, 2188–2194 (2002). Review of the history of the discovery and development of drugs for neglected diseases, making it clear that non-market-driven mechanisms are required to stimulate new drug development
2. Global Forum for Health Research. The 10/90 Report on Health Research, 2003–2004 (Global Forum for Health Research, Geneva, 2004).
3. Médecins Sans Frontières Access to Essential Medicines Campaign. Fatal Imbalance: The crisis in Research and Development for Drugs for Neglected Diseases (Médecins Sans Frontières, Geneva, 2001).
4. Nwaka, S. & Ridley, R. G. Virtual drug discovery and development for neglected diseases through public-private partnerships. Nature Rev. Drug Discov. 2, 919–928 (2003). A clear discussion of the role and importance of public-private partnerships.
5. Kettler, H. E. & Marjanovic, S. Engaging biotechnology companies in the development of innovative solutions for diseases of poverty. Nature Rev. Drug Discov. 3, 171–176 (2004).
Cited by
439 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献